Pfizer annual operating margin
2022
2023
2024
2025
Pfizer's operating margin was 27.82% for fiscal 2025.
View full Pfizer company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 27.82% | +4.34 pp |
| 2024 | 2024-12-31 | 23.48% | +14.80 pp |
| 2023 | 2023-12-31 | 8.68% | −32.85 pp |
| 2022 | 2022-12-31 | 41.52% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-28 | 23.53% | −2.18 pp |
| Q1 2026 | 2026-03-29 | 29.53% | — |
| Q4 2025 | 2025-12-31 | 21.00% | — |
| Q3 2025 | 2025-09-28 | 33.19% | — |
| Q2 2025 | 2025-06-29 | 25.71% | — |
Between the periods ended 2022-12-31 and 2025-12-31, Pfizer's operating margin decreased from 41.52% to 27.82%, a change of −13.71 percentage points. The latest reported quarter, Q2 2026, shows 23.53%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pfizer source filings ↗